Camber rolls out generic Thyro-Tabs
Levothyroxine sodium tablets are indicated as replacement therapy in primary, secondary and tertiary congenital or acquired hypothyroidism.
Camber is offering levothyroxine sodium tablets, which are the generic of Thryo-Tabs.
Levothyroxine sodium tablets are indicated as replacement therapy in primary (thyroidal), secondary (pituitary) and tertiary (hypothalamic) congenital or acquired hypothyroidism. The tablets are also indicated as an adjunct to surgery and radioiodine therapy in managing thyrotropin-dependent well-differentiated thyroid cancer.
[Read more: Camber debuts generic Vesicare]
Levothyroxine sodium tablets are available in 25, 50, 75, 88, 100, 112, 125, 137, 150, 175, 200 and 300 mcg strengths and supplied in 90- and 1000-count bottles.